1 in 10
medicines in low- and middle-income countries were estimated to fail quality tests in WHO’s 2017 estimate
Low- and middle-income countries · 2017 estimate, restated in 2024
Historical quality-test estimate, not an expiry rate or a pharmacy stock-loss percentage. Inventory records cannot determine medicine authenticity or clinical suitability.
Operational takeaway: Maintain supplier documentation and evaluate traceability requirements with qualified pharmacy staff.
WHO · Substandard and falsified medical productsPublished